Advertisement

Topics

CORRECTING and REPLACING Xcell Biosciences Initiates New Collaborations with UCSF Researchers Studying Effectiveness of Immunotherapy in Urologic Cancers

05:30 EDT 23 Sep 2016 | Biotech-Finances

Thursday, September 22nd 2016 at 4:12pm UTC Studies Assess the Ability to Predict Prognosis and Response to Therapies by Immunoprofiling of Patients’ Blood, Cultured and Conditioned with Xcell’s Unique Avatar System SAN FRANCISCO–(BUSINESS WIRE)– Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: XCELL BIOSCIENCES INITIATES NEW …

Cet article CORRECTING and REPLACING Xcell Biosciences Initiates New
Collaborations with UCSF Researchers Studying Effectiveness of
Immunotherapy in Urologic Cancers
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: CORRECTING and REPLACING Xcell Biosciences Initiates New Collaborations with UCSF Researchers Studying Effectiveness of Immunotherapy in Urologic Cancers

NEXT ARTICLE

More From BioPortfolio on "CORRECTING and REPLACING Xcell Biosciences Initiates New Collaborations with UCSF Researchers Studying Effectiveness of Immunotherapy in Urologic Cancers"

Quick Search
Advertisement